"A NATURAL IMMUNE SYSTEM ACTIVATOR DERIVED FROM BAKER'S YEAST:

Ever since the 1940s, scientists have been honing their knowledge of the remarkable abilities of a simple substance derived from baker's yeast to effectively stimulate and activate the immune system and to work therapeutically in cancer, ulcers, radiation exposure, infection and trauma.

The name of this substance is Beta-1,3-Glucan. The research supporting the claims for beta glucan as an immune system activator has been building steadily in recent decades. In 1996 alone, 144 scientific studies were published on the medical uses of beta glucan. One fact has consistently emerged from these studies: beta glucan produces its multiple broad-scale immune effects by being a nonspecific immune stimulator. This means it causes a response capable of being directed at many conditions, perhaps all.

Research at Harvard University in the 1980s showed that the macrophage - a key immune system white blood cell that "eats" unwanted, foreign microbes - has a specific receptor for beta glucan. In non-technical terms, we might say the yeast talks directly to the immune cell. When the macrophage is activated by this contact, it starts a "cascade of events turning the cells into an 'arsenal of defense'" explains Donald J. Carrow, M.D., a physician based in Tampa, Florida, who has used beta glucan successfully with many patients.

Dr. Carrow further notes that the specificity of this macrophage receptor site may explain why beta glucan "is one of the most potent stimulators of the immune response". Dr. Carrow says that "there is now evidence to show that beta glucan is, from an evolutionary point of view, the most widely and most commonly observed macrophage activator in nature."

Beta glucan's beneficial role in treating cancer was illuminated in 1975 by Peter W. Mansell, M.D., and colleagues, as reported in the Journal of the National Cancer Institute. Nodules of malignant skin cancer in nine patients were injected with beta glucan. The size of the cancer lesions was "strikingly reduced in as short a period as five days" and in small lesions "resolution was complete," Dr. Mansell reported.
In the mid-1980s, researchers at Tulane University School of Medicine reported that beta glucan injected directly into chest-wall malignant ulcers (in women who had already undergone mastectomy and radiation therapy for breast cancer) healed the sores completely.
Beta glucan radiation protection effects were shown in 1985 when the U.S. Armed Forces Radiobiology Research Institute announced the results of their recent experiments. Myra D. Patchen, M.D., and her team at the Institute exposed mice to lethal doses of radiation. When the mice were given an oral dose of beta glucan after the radiation exposure, 70% were completely protected from the damaging effects.
The ingestion produced measurable increases in the production of key immune cell components, Dr. Patchen reported. She also suggested that beta dlucan should be considered as an effective way of rebuilding the immune system and preventing infection following chemotherapy and radiation in cancer treatment.
Dr. Patchen further suggested that beta glucan appears to work as a free radical scavenger. She believes it may even protect the macrophages from damage by radiation, toxins, heavy metals, invading microbes, and other poisons (collectively called free radicals) in the body.

William Browder, M.D., of Tulane University in New Orleans reported on the benefits of using beta glucan to stimulate immune response and prevent infection in patients undergoing surgery for physical trauma. In his study, 21 patients received beta glucan intravenously every day for one week. Dr. Browder reported that the incidence of infection in these patients was "significantly reduced" compared to the rate among those who did not receive glucan therapy. The glucan-treated patients also had a greater increase in key immune factors within three days and a much lower mortality rate (0% compared to 29%) than the non-glucan-treated group.
In his own clinical practice, Dr. Carrow has tested beta glucan on a variety of conditions, including cancer and ulcers, and for general health maintenance. Dr. Carrow injected a skin cancer lesion with 10 mg of beta-1,3-glucan and within three month the tumor had completely disappeared, he reports. Five breast cancer patients undergoing radiation took 7.5 mg daily of beta glucan and were free of radiation injuries to the skin. By applying beta glucan topically to ulcers on two patients, Dr. Carrow was able to heal them completely within two months.

From the above cases it is obvious that beta glucan is a powerful adjunctive agent in an anti-cancer protocol. It is not a cure, but it can assist in controlling and reversing cancer in an effective and beneficial way. It is reported to be entirely non-toxic."

NAME OF MEDICATION: Beta-1,3-Glucan
SOURCE:
Light Resources Unlimited Inc.
3439 S.E. Sandy Blvd., Suite 259 Portland, Oregon 97232 Tel:1-888-342-3530 or 503-229-1052
AMERIDEN
P.O. Box 1870 Fallbrook, CA 92088 Tel: 760-728-0747
ImmuDyne, Inc.
11200 Wilcrest Green Dr.
Houston, TX 77042
Tel: 713/783-7034
Fax: 713/783-6819 Toll free 1-888-246-6839

COST: Approx. $30 - 35 for a bottle of 60 capsules. Available also in oral spray form.

TOP

INDEX